Cargando…
Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP)
INTRODUCTION: The incidence of intrauterine growth restriction (IUGR) is estimated at about 3% of pregnancies, and it is associated with 30% of all perinatal mortality and severe morbidity with adverse neurodevelopmental and cardiovascular health consequences in adult life. Early onset IUGR represen...
Autores principales: | Mazarico, Edurne, Peguero, Anna, Camprubí, Marta, Rovira, Carlota, Gomez Roig, Maria Dolores, Oros, Daniel, Ibáñez-Burillo, Patricia, Schoorlemmer, Jon, Masoller, Narcís, Tàssies, Maria Dolors, Figueras, Francesc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224717/ https://www.ncbi.nlm.nih.gov/pubmed/30355790 http://dx.doi.org/10.1136/bmjopen-2017-020501 |
Ejemplares similares
-
Postnatal Anthropometric and Body Composition Profiles in Infants with Intrauterine Growth Restriction Identified by Prenatal Doppler
por: Mazarico, E., et al.
Publicado: (2016) -
Correction: Postnatal Anthropometric and Body Composition Profiles in Infants with Intrauterine Growth Restriction Identified by Prenatal Doppler
por: Mazarico, E., et al.
Publicado: (2016) -
Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial*
por: Ørbo, A, et al.
Publicado: (2014) -
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
por: Ørbo, A, et al.
Publicado: (2015) -
Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis
por: Huang, Jinzhu, et al.
Publicado: (2019)